Visiting Scientist Resume Example

Challenging position as postdoctoral scientist incorporating skills in immunological research, drug design and development, and immunotherapy

• Keynote speaker, PhD students annual seminar, Fraunhofer Institute, 2013.
• ForSaTum grant for Doctoral studies. 2010-2013.
• Dean's Honor for accomplishments in Bachelor's studies, 2004.

Laboratory Animals Research training. Certification to work with laboratory animals from the Technion Institute of Technology, and Stanford University.

Flow Cytometry training. training to work with BD FACSCalibur™ and BD LSRFORTESSA.

Confocal microscopy training. intensive course in confocal microscopy, working on Leica TCS SP5 microscope.

Cell and Molecular Biology Techniques: Bacterial cultures, human and mouse cell lines and primary cells, Immuno-assays, Cloning, PCR, RT-PCR, Drug Evaluation assays, Flow Cytometry, Microscopy.

Work with Laboratory Mice: tumor xenografts models, EAE, colitis model, Immunological studies with transgenic and chimeric mice models, in vivo live imaging.

Recombinant Proteins: Design and expression-Mammalian and Bacterial systems, Protein and antibody Purification.

Data Analysis and Documentation: statistical data analysis, sequence analysis (DNA and Protein). Work in BSL-2 and S2-GMP lab, documentation under the German Genetic Engineering Safety Regulations (GenTSV)

Computer Skills: Microsoft Office, CLC workbench, Gimp, GraphPad PRISM software, AIDA image analyzer, FlowJo, BD cell quest, BD FACS Diva, work with NCBI, Immgen and UniProt databases

1. Hristodorov D*, Amoury M*, et al. EpCAM-selective elimination of carcinoma cells by a novel MAP-based cytolytic fusion protein. Mol Cancer Ther. 2014 Sep;13(9):2194-202. PubMed PMID: 24980949.

* shared first authors

2. Reis BS, Lee K, Fanok MH, Mascaraque C, Amoury M, et al. Leptin receptor signaling in T cells is required for Th17 differentiation. J Immunol. 2015 Jun 1;194(11):5253-60. PubMed PMID: 25917102.

3. Amoury M, Blume T, et al. SNAP-tag based agents for preclinical in vitro imaging in malignant diseases. Curr Pharm Des. 2013;19(30):5429-36. PubMed PMID: 23431985.

4. Hussain AF, Amoury M, Barth S. SNAP-tag technology: a powerful tool for site specific conjugation of therapeutic and imaging agents. Curr Pharm Des. 2013;19(30):5437-42. Review. PubMed PMID: 23431986.

Submitted manuscripts (not published yet): 

1. Manal Amoury, Stefan Barth et al. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model. (Submitted to Cancer letters)

2. Manal Amoury, Dirk Bauerschlag, Ahmad Fawzi Hussain et al. On demand activatable photoimmuno-theranostics for triple negative breast cancer cells diagnosis and treatment

(submitted to theranostics)

3. Manal Amoury, Radoslav Mladenov, Stefan Barth et al. A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein. (Submitted to Int. J of Cancer, currently working on revisions)